Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

less than the 25% the company had expected. Meanwhile, the company actually was pleased with the result, with Novo Nordisk's vice president saying: We are encouraged by the weight loss profile of ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as the largest drugmaker in the world, with a market cap of $844 billion ...

Hims & Hers Health (HIMS) is an intriguing stock strategically positioned in the rapidly expanding telehealth market. However, this week’s ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

There are three medicines approved by the US Food and Drug Administration for AUD, but fewer than 2% of people with ... Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy ...

It’s a bigger deal than any deal announced in 2024 ... the dealmaking environment from a regulatory perspective." Novo Nordisk’s global head of business development and M&A, John MacDonald ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as the largest drugmaker in the world, with a market cap of $844 billion, ...

Acquired hosts Ben Gilbert and David Rosenthal take GQ behind the scenes of their epic deep dive into the world’s biggest ...